Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913702 · ClinicalTrials.gov registry record · Phase 2
Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03913702 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1 participants.
The verdict
NCT03913702, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.
Interventions
- DRUG Ketorolac Tromethamine
- DRUG Methylprednisolone Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2022-11-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03913702
The ClinicalTrials.gov registry entry for NCT03913702 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac Tromethamine is the first listed.
NCT03913702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03913702 about?
NCT03913702 is a clinical study titled "Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement". The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.
What is the current status of trial NCT03913702?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2019-09-09. Estimated completion is 2022-11-02.
What interventions are being tested in trial NCT03913702?
The interventions under investigation include: Ketorolac Tromethamine (DRUG), Methylprednisolone Acetate (DRUG).
Who is sponsoring clinical trial NCT03913702?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.